GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bloomios Inc (OTCPK:BLMS) » Definitions » Cyclically Adjusted PS Ratio

Bloomios (Bloomios) Cyclically Adjusted PS Ratio : 0.00 (As of Jun. 22, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Bloomios Cyclically Adjusted PS Ratio?

As of today (2024-06-22), Bloomios's current share price is $0.0009. Bloomios's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was $0.50. Bloomios's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for Bloomios's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, Bloomios's highest Cyclically Adjusted PS Ratio was 1.57. The lowest was 0.01. And the median was 0.01.

BLMS's Cyclically Adjusted PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.06
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bloomios's adjusted revenue per share data for the three months ended in Sep. 2023 was $0.011. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.50 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bloomios Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bloomios's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomios Cyclically Adjusted PS Ratio Chart

Bloomios Annual Data
Trend Jun02 Jun03 Jun04 Jan05 Jan06 Jan07 Jan19 Jan20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bloomios Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.49 0.10 0.01

Competitive Comparison of Bloomios's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bloomios's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bloomios's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bloomios's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bloomios's Cyclically Adjusted PS Ratio falls into.



Bloomios Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bloomios's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0009/0.5
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bloomios's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Bloomios's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.011/129.8595*129.8595
=0.011

Current CPI (Sep. 2023) = 129.8595.

Bloomios Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200303 0.000 77.716 0.000
200306 0.000 77.505 0.000
200309 0.000 78.138 0.000
200312 0.000 77.758 0.000
200403 0.000 79.066 0.000
200406 0.000 80.037 0.000
200410 0.000 80.543 0.000
200501 0.000 80.458 0.000
200504 0.000 82.104 0.000
200507 0.000 82.441 0.000
200510 0.000 84.045 0.000
200601 0.000 83.665 0.000
200604 0.000 85.015 0.000
200607 0.000 85.859 0.000
200610 0.000 85.142 0.000
200701 0.000 85.402 0.000
200704 0.000 87.203 0.000
200707 0.000 87.884 0.000
200710 0.000 88.152 0.000
201807 0.000 106.324 0.000
201810 0.000 106.695 0.000
201901 0.000 106.200 0.000
201904 0.000 107.818 0.000
201907 0.000 108.250 0.000
201910 0.000 108.577 0.000
202001 0.000 108.841 0.000
202004 0.000 108.173 0.000
202007 0.000 109.318 0.000
202010 0.000 109.861 0.000
202103 0.173 111.754 0.201
202106 0.099 114.631 0.112
202109 0.175 115.734 0.196
202112 0.131 117.630 0.145
202203 0.116 121.301 0.124
202206 0.096 125.017 0.100
202209 0.091 125.227 0.094
202212 0.156 125.222 0.162
202303 0.108 127.348 0.110
202306 0.105 128.729 0.106
202309 0.011 129.860 0.011

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bloomios  (OTCPK:BLMS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bloomios Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bloomios's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bloomios (Bloomios) Business Description

Traded in Other Exchanges
N/A
Address
701 Anacapa Street, Suite C, Santa Barbara, CA, USA, 93101
Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.
Executives
Douglas S Rohrer officer: Chief Business Officer 701 ANACAPA, SUITE C, SANTA BARBARA CA 93101
Emc2 Capital Llc 10 percent owner 201 W MONTECITO STREET, SANTA BARBARA CA 93101
Barrett Evans director, 10 percent owner, officer: Pres, Chief Strategy Officer
Aline Hayuta Elkayam 10 percent owner 104 CHELSEA PLACE, ORMOND BEACH FL 32174
Bibi Daprile 10 percent owner 12 WINDING CREEK WAY, ORMOND BEACH FL 32174
Agpl Acquisition, Inc 10 percent owner 201 W MONTECITO ST., SANTA BARBARA CA 93101
Mammoth Crest Capital Llc 10 percent owner 1712 PIONEER AVE, SUITE 558, CHEYENNE WY 82001
Michael Hill director, 10 percent owner, officer: Chief Executive Officer 201 WEST MONTECITO STREET, SANTA BARBARA CA 93101
Bryan Glass director, 10 percent owner, officer: President and Director 20 WEST PARK AVENUE, SUITE 207, LONG BEACH NY 11561
Douglas Boyd director, officer: Chairman of the Board 8101 TIARA COVE CIR, LAS VEGAS NV 89128
Peter A Hogendoorn director, officer: President & CEO 13288 AMBLE GREEN PLACE, SURREY A1 V4A 6P5
Harold C Moll director, 10 percent owner
Van Laare Derek R officer: Secretary 6119 GORDON AVENUE, BURNABY A1 V5E 3M2
Carlo Civelli other: former director/officer/owner 111 SOMERSET ROAD, TRIPLE ONE SOMERSET 06-06, SINGAPORE U0 238164
Logan Anderson director, officer: President & Treasurer 15 HILL CRESCENT, PEMBROKE BERMUDA D8 00000